A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects

for the OBES-002 Study Group, Wilding, J, Gaal, L Van, Rissanen, A, Vercruysse, F, Fitchet, M·2004·International Journal of Obesity
DOI 10.1038/sj.ijo.0802783

Cited by (224)

Items 101–200 of 224

  1. Medical Therapy for Obesity—Current Status and Future Hopes
    George A. Bray · 2007 · Medical Clinics of North America
  2. Medications for Obesity: Mechanisms and Applications
    George A. Bray · 2009 · Clinics in Chest Medicine
  3. Emerging pharmacotherapy for obesity
    Louis J. Aronne, Amanda G. Powell, Caroline Margaret Apovian · 2011 · Expert Opinion on Emerging Drugs
  4. Obesity Management Interventions: A Review of the Evidence
    Joseph C. Yaskin, Richard W. Toner, Neil I. Goldfarb · 2009 · Population Health Management
  5. Past and present of antiobesity agents: Focus on monoamine modulators
    Farah Khorassani, Anne D. Misher, Shauna Garris · 2015 · American Journal of Health-System Pharmacy
  6. Medications for Weight Reduction
    George A. Bray · 2008 · Endocrinology and Metabolism Clinics of North America
  7. Topiramate (Topamax): Evolving Role in Weight Reduction Management: A Narrative Review
    Irza Wajid, Alexis Vega, Katherine Thornhill, Jack S. Jenkins, Chandler Merriman, Debbie Chandler, Sahar Shekoohi, Elyse M. Cornett, Alan D. Kaye · 2023 · Life
  8. Management of Obesity-Induced Kidney Disease: A Critical Review of the Literature
    D. Kiortsis, M. Christou · 2012 · Obesity Facts
  9. Neuropeptide receptors as potential pharmacological targets for obesity
    Beatriz T. Meneguetti, Marlon Henrique e Silva Cardoso, Camila Fontoura Acosta Ribeiro, Mário R. Felício, Ingrid Batista Pinto, Nuno C. Santos, Cristiano Marcelo Espínola Carvalho, Octávio Luiz Franco · 2018 · Pharmacology & Therapeutics
  10. The effects of topiramate and valproate therapy on insulin, c-peptide, leptin, neuropeptide Y, adiponectin, visfatin, and resistin levels in children with epilepsy
    Fatma Müjgan Sönmez, Dilek Zaman, Ayşe Aksoy, Orhan Değer, Rezzan Aliyazıcıoğlu, Gülay Karagüzel, Kerim Fazlıoğlu · 2013 · Seizure
  11. Anti-obesity drugs
    Robert F. Kushner · 2008 · Expert Opinion on Pharmacotherapy
  12. Weight variations in patients receiving topiramate migraine prophylaxis in a tertiary care setting.
    Abouch Valenty Krymchantowski, Claudia Baptista Tavares · 2004 · PubMed Central
  13. The effects of valproate and topiramate use on serum insulin, leptin, neuropeptide Y and ghrelin levels in epileptic children
    Nafiye Polat Çiçek, Tülay Kamaşak, Hepsen Mine Serin, Ayşenur Ökten, Ahmet Alver, Ali Cansu · 2018 · Seizure
  14. The effect of topiramate on weight loss in patients with type 2 diabetes.
    Sedighe Moradi, Scott Reza Jafarian Kerman, Mina Mollabashi · 2013 · Europe PMC (PubMed Central)
  15. Is Acetazolamide Similar to Topiramate for Reversal of Antipsychotic-Induced Weight Gain?
    Mark E. Schneiderhan, Robert G. Marvin · 2007 · American Journal of Therapeutics
  16. Disorders of Energy Balance
    Robert H. Lustig, Ram Weiss · 2008 · Elsevier eBooks
  17. Weight Regain after Discontinuation of Topiramate Treatment in Patients with Migraine: a Prospective Observational Study
    Alberto Verrotti, Pasquale Parisi, Sergio Agostinelli, Giulia Loiacono, Francesca Marra, Giangennaro Coppola, Laura Rosa Pisani, Gaetano Gorgone, Pasquale Striano, Francesco Pisani et al. · 2015 · CNS Drugs
  18. Optimizing therapy of seizures in patients with endocrine disorders
    Bernhard Jochen Steinhoff · 2006 · Neurology
  19. Drug Treatment of Obesity in Cardiovascular Disease
    Marietta Charakida, Nick Finer · 2012 · American Journal of Cardiovascular Drugs
  20. Seizures in brain tumors: pathogenesis, risk factors and management (Review)
    Cyrille D Dantio, Deborah Oluwatosin Fasoranti, Chubei Teng, Xuejun Li · 2025 · International Journal of Molecular Medicine
  21. Obesity
    Helen M. Seagle, Holly R. Wyatt, James O. Hill · 2012 · Elsevier eBooks
  22. Long-term topiramate treatment of psychotropic drug-induced weight gain: a retrospective chart review
    Yasser Khazaal, Anne Chatton, Manon Rusca, Martin Preisig, DANIELE FABIO ZULLINO · 2007 · General Hospital Psychiatry
  23. Fixed-dose combination of phentermine–topiramate for the treatment of obesity
    Bruno Halpern, André Murad Faria, Alfredo Halpern · 2013 · Expert Review of Clinical Pharmacology
  24. Long-lasting remission of type 1 diabetes following treatment with topiramate for generalized seizures
    Alberto M. Davalli, Carla Perego, Franco B. Folli, Emanuele Bosi · 2011 · Acta Diabetologica
  25. The Effective Use of Anti-obesity Medications
    Sarah H. Schmitz, Louis J. Aronne · 2023 · Gastroenterology Clinics of North America
  26. Aversion to Off-label Prescribing in Clinical Pediatric Weight Management: The Quintessential Double Standard
    Christine B. San Giovanni, Brooke R. Sweeney, Joseph A. Skelton, Megan Moriarty Kelsey, Aaron S. Kelly · 2021 · The Journal of Clinical Endocrinology & Metabolism
  27. Medications for Weight Reduction
    George A. Bray · 2011 · Medical Clinics of North America
  28. Topiramate for weight reduction in duchenne muscular dystrophy
    Gregory T. Carter, Michelle P. Yudkowsky, Jay J. Han, Megan A. McCrory · 2005 · Muscle & Nerve
  29. Topiramate effects lipolysis in 3T3-L1 adipocytes
    GABRIELA POLTRONIERI CAMPAGNARO MARTINS, Camila Oliveira de Souza, Schérolin de Oliveira Marques, Thais F. Luciano, Bruno Luiz da Silva Pieri, José Cesar Rosa Neto, Adelino Sánchez Ramos da Silva, José Rodrigo Pauli, Dennys E. Cintra, Eduardo Rochete Ropelle et al. · 2015 · Biomedical Reports
  30. Pharmacotherapy for obesity
    Kyoung Kon Kim · 2011 · Journal of Korean Medical Association
  31. Hypothalamic Regulatory Pathways and Potential Obesity Treatment Targets
    Erin E. Jobst, Pablo J. Enriori, Puspha Sinnayah, Michael Alexander Cowley · 2006 · Endocrine
  32. Developmental Regression Followed by Epilepsy and Aggression: A New Syndrome in Autism Spectrum Disorder?
    John N. Gaitanis, Duyu A. Nie, Tao Hou, Richard E. Frye · 2023 · Journal of Personalized Medicine
  33. Obesity, metabolic syndrome, and disorders of energy balance
    Ram Weiss, Robert H. Lustig · 2014 · Elsevier eBooks
  34. Pharmacological Treatment of the Overweight Patient
    2007 · Humana Press eBooks
  35. Dietary and Medical Therapy of Obesity
    Phyllis Stumbo, Donna Hemingway, William Geoffrey Haynes · 2005 · Surgical Clinics of North America
  36. Efficacy of Oral Medication in Weight Loss Management: A Systematic Review and Network Meta-Analysis
    Benedictus Benedictus, Vincent Kurniawan Putra Pratama, Christopher William Purnomo, Kenneth Tan, Ratih Puspita Febrinasari · 2025 · Clinical Therapeutics
  37. Pharmacologic management of obesity
    Robert F. Kushner · 2011 · Pediatric Blood & Cancer
  38. Clinical effectiveness and predictors of response to topiramate plus lifestyle modification in youth with obesity seen in a weight management clinical setting
    Eric Morris Bomberg, Justin Clark, Kyle D. Rudser, Amy C. Gross, Aaron S. Kelly, Claudia K. Fox · 2024 · Frontiers in Endocrinology
  39. Cutting-Edge Approaches to Obesity Management: The Latest Pharmacological Options
    Sarah H. Schmitz, Katherine H. Saunders, Louis J. Aronne · 2025 · Endocrinology and Metabolism Clinics of North America
  40. Translational Modeling to Guide Study Design and Dose Choice in Obesity Exemplified by AZD1979, a Melanin‐concentrating Hormone Receptor 1 Antagonist
    Peter Gennemark, Magnus Trägårdh, Daniel Lindén, Karolina Ploj, Anders Johansson, Andrew V. Turnbull, Björn Carlsson, Madeleine Antonsson · 2017 · CPT Pharmacometrics & Systems Pharmacology
  41. Of mice and men: Why progress in the pharmacological management of obesity is slower than anticipated and what could be done about it?
    Chrysoula Boutari, Stergios A. Pοlyzos, Christos Socrates Mantzoros · 2019 · Metabolism
  42. Clinical Investigations of Antiobesity Drugs
    John P.H. Wilding · 2007 · Elsevier eBooks
  43. Antiobesity medications in adult and pediatric obesity and metabolic dysfunction–associated steatotic liver disease
    Natalie S. Rodriguez, Phillipp Hartmann · 2025 · Pharmacological Reviews
  44. New molecular targets in the pathophysiology of obesity and available treatment options under investigation
    Georgios Valsamakis, Konstantinos B. Lois, Sudhesh Kumar, George P. Mastorakos · 2014 · Clinical Obesity
  45. Preclinical Developments in Antiobesity Drugs
    Steve P. Vickers, Sharon C. Cheetham · 2007 · Elsevier eBooks
  46. Phentermine–topiramate extended release for the dual treatment of obesity and sleep-related eating disorder: a case report
    Eduardo L. Grunvald, Jennifer DeConde · 2022 · Journal of Medical Case Reports
  47. Presente y futuro del tratamiento farmacológico de la obesidad
    Mónica Díaz · 2026 · Revista Argentina de Cardiología
  48. Short-term topiramate treatment does not improve insulin sensitivity or secretion in obese insulin-resistant women
    Maria A. Sleddering, Marieke Snel, Trea C.M. Streefland, Hanno Pijl, Ingrid M. Jazet · 2012 · European Journal of Endocrinology
  49. Continuous monitoring devices and seizure patterns by glucose, time and lateralized seizure onset
    Katie M. Kinnear, Nicole M. Warner, Alan M. Haltiner, Michael John Doherty · 2018 · Epilepsy & Behavior Case Reports
  50. Perampanel-induced weight gain depends on level of intellectual disability and its serum concentration
    Hirotaka Iwaki, Kazutaka Jin, Norio Sugawara, Nobukazu Nakasato, Sunao Kaneko · 2019 · Epilepsy Research
  51. Review: Pharmacological approaches to reduce adiposity
    Caroline Day, Clifford J. Bailey · 2006 · The British Journal of Diabetes
  52. Changes in metabolic syndrome parameters in patients with schizoaffective disorder who participated in a randomized, placebo-controlled trial of topiramate
    Ranita Basu, T.G. Thimmaiah, Jatinder Mohan Chawla, Patricia J. Schlicht, Andrea M. Fagiolini, Jaspreet Singh Brar, Shakeel Ahmed Khan, Anuradha Challa, K. N. Roy Chengappa · 2009 · Asian Journal of Psychiatry
  53. Current Options for the Pharmacotherapy of Obesity
    Ioanna Gouni‐Berthold, Heiner K. Berthold · 2019 · Current Pharmaceutical Design
  54. Long‐Term Medication‐Induced Weight Change Across Common Antiseizure Medications: A Target Trial Emulation Study
    Han Yu, Jessica G. Young, Joshua Petimar, Sheryl L. Rifas‐Shiman, Matthew F. Daley, William J. Heerman, David M. Janicke, W. Schuyler Jones, Takuya Kawahara, Kristina Henderson Lewis et al. · 2025 · Obesity
  55. Topiramate treatment of pediatric metabolic dysfunction–associated steatotic liver disease: A descriptive cohort study
    Taisa J. Kohut, Andrea M. Tou, Emily Carr, Stavra A. Xanthakos, Ana Catalina Arce‐Clachar, Rima L. Fawaz, Pamela L. Valentino, Jennifer A. Panganiban, Marialena Mouzaki · 2024 · Journal of Parenteral and Enteral Nutrition
  56. The Effect of Flavonoids and Topiramate on Glucose Carbon Metabolism in a HepG2 Steatosis Cell Culture Model: A Stable Isotope Study
    Li Ma, Qing‐Yi Lu, Shu K. Lim, Guang Han, László G. Boros, Mina Desai, Jennifer K. Yee · 2025 · Nutrients
  57. Recent Advances in Anti-Obesity Drugs
    Jang Won Son · 2022 · Journal of Korean Diabetes
  58. Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines
    Marcelo Correia, William Geoffrey Haynes · 2005 · Expert Opinion on Emerging Drugs
  59. Antiepileptic Drugs in Obesity, Psychotropic-Associated Weight Gain, and Eating Disorders
    Susan L. McElroy, Anna I. Guerdjikova, Paul E. Keck, Harrison Graham Pope, James I. Hudson · 2008 · Medical psychiatry
  60. Topiramate-induced weight loss depends on level of intellectual disability in patients with epilepsy
    Hirotaka Iwaki, Kazutaka Jin, Mayu Fujikawa, Nobukazu Nakasato, Sunao Kaneko · 2018 · Epilepsy & Behavior
  61. Pharmacological Management of Obesity
    George A. Bray · 2005 · KARGER eBooks
  62. Regulación de la ingesta alimentaria: una perspectiva clínica
    Javier Salvador, Gema Frühbeck · 2005 · Endocrinología y Nutrición
  63. Anti-obesity Effects of African Mango (Irvingia gabonesis, IGOB 131TM) Extract in Leptin-deficient Obese Mice
    Minhee Lee, Da‐Eun Nam, Ok Kyung Kim, Tae Jin Shim, Ji Hoon Kim, Jeongmin Lee · 2014 · Journal of the Korean Society of Food Science and Nutrition
  64. Weight-Loss Drugs
    George A. Bray, Frank L. Greenway · 2007 · Humana Press eBooks
  65. Obesity, a burning problem
    Arunima Chaudhuri Dr. Arunima Chaudhuri · 2014 · IOSR Journal of Pharmacy (IOSRPHR)
  66. Obesity Pharmacotherapy: a Review of Current Practices and Future Directions
    Sarah H. Schmitz, Beverly G. Tchang, Alpana P. Shukla · 2023 · Current Treatment Options in Gastroenterology
  67. Assessment of the Obese Patient
    Daniel H. Bessesen · 2014 · Springer eBooks
  68. Synchronous neuronal interactions in rat hypothalamic culture: a novel model for the study of network dynamics in metabolic disorders
    Vijayakumar Mavanji, Apostolos P. Georgopoulos, Catherine M. Kotz · 2021 · Experimental Brain Research
  69. Drugs Used Clinically to Reduce Body Weight
    George A. Bray · 2009 · Wiley eBooks
  70. Randomized study of the effects of empagliflozin and topiramate dual therapy on anthropometric and metabolic indices in non-diabetic individuals with overweight/obesity on a calorie-restricted diet
    Behnaz Abiri, Amirhossein Ramezani Ahmadi, Farhad Hosseinpanah, Ali Valizadeh, Afshin Zarghi, Majid Valizadeh · 2024 · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity
  71. Another Type of Intervention: Treating Obesity with Medication
    Frank L. Greenway · 2005 · Journal of the American Dietetic Association
  72. Obesity and binge eating disorder
    2006 · Acta Paediatrica
  73. Mechanisms of action and clinical applications of anti-obesity drugs currently available in Korea
    Kyoung Kon Kim · 2019 · Journal of Korean Medical Association
  74. Extinguishing the Fire: Treating Pediatric Type 2 Diabetes by Targeting Obesity Treatment
    Megan O. Bensignor, Daniel S. Hsia, Michelle Anne Van Name, Ania M. Jastreboff, Justin R. Ryder · 2025 · Diabetes Care
  75. A Hybrid Lifestyle Program and Metabolic Health in Adults With Obesity
    Graziele Souza de Menezes Amorim Coelho, Ariana Ester Fernandes, Renata Bressan Pepe, Patrícia Aparecida Cruz, Andréa Samara Audi, Cíntia Cercato, Márcio C. Mancini, Maria Edna de Melo · 2026 · JAMA Network Open
  76. Pharmacologic Approaches to Type 2 Diabetes and Obesity in Children and Adolescents
    Patama Pongsuwan · 2011 · Humana Press eBooks
  77. Update on Anti-obesity Medications
    Kyung‐Hee Park · 2005 · Journal of the Korean Medical Association
  78. Medical Management of Obesity
    Bruno Halpern, Gustavo Daher, Alfredo Halpern · 2013 · Springer eBooks
  79. Prevention and Treatment of Childhood Obesity and Metabolic Syndrome
    Sani M. Roy, Stacy E. Rustico, Bassil M. Kublaoui · 2015 · Springer eBooks
  80. Membrane Stabilizers for the Treatment of Pain
    Robert W. Hurley, Brian E. McGeeney, Charles E. Argoff · 2013 · Elsevier eBooks
  81. Obesity: Medical and Surgical Treatment
    Daniele Tassinari, Alessandro Giovanelli, Carmela Asteria · 2021 · Springer eBooks
  82. Medical Management of Obesity Associated with Mood Disorders
    Susan L. McElroy, Renu Kotwal, Paul E. Keck · 2006 · CRC Press eBooks
  83. PSYCHIATRIC MEDICATIONS AND METABOLIC SYNDROME
    Scott D. Mendelson · 2008 · Elsevier eBooks
  84. Obesity and Mood Disorders
    Susan L. McElroy, Renu Kotwal, Erik B. Nelson, Shishuka Malhotra, Paul E. Keck, Charles B. Nemeroff · 2006 · CRC Press eBooks
  85. Prevention and Treatment of Obesity in Children
    Talia A. Hitt, Katie L. Wasserstein, Sara N. Malina, Sheela Natesh Magge · 2023 · Springer eBooks
  86. Impact of an outpatient dietary intervention on antipsychotic-induced weight gain
    Yasser Khazaal, Cloé Charpentier, Stéphane Rothen, Emmanuelle Frésard, DANIELE FABIO ZULLINO · 2006 · Archive ouverte UNIGE (University of Geneva)
  87. Neuropharmacology of obstructive sleep apnea and central apnea
    Peter R. Buchanan, Ronald R. Grunstein · 2006 · Birkhäuser-Verlag eBooks
  88. Topiramate
    Judith Helen Cross, Catherine J. Riney · 2015
  89. Güncel Cerrahi Tedavi
    Adem Aslan, Tuba Mert, Burak Uçaner, Oğuz Hançerlioğulları, Çağdaş Karaman, Mehmet Sabri Çiftçi, Serdar Acar, Seda Sezen Göktaş, Zeynep Anadolulu, Murat Özkara et al. · 2023 · Akademisyen Kitabevi eBooks
  90. Migraine, Neurogenic Inflammation, and Cardiovascular Risk: A Pharmacoepidemiologic Study of ACEI/ARB and Anti-CGRP Treatment
    Kaicheng Wang, Brenda T. Fenton, John P. Ney, Vinh X. Dao, Haidong Lu, Alexander B. Guirguis, Emmanuelle A. D. Schindler, Adam de Havenon, Melissa Skanderson, Sarah E. Anthony et al. · 2025 · medRxiv
  91. A Status of Drugs on the Horizon for Obesity and the Metabolic Syndrome—a Comprehensive Review 2005
    Frank L. Greenway, George A. Bray · 2007 · Springer eBooks
  92. Gewichtsveränderungen unter Antiepileptikagabe
    Felix Rosenow, Hajo M. Hamer, Karl Martin Klein · 2009 · Clinical Epileptology
  93. Principles of Obesity Therapy
    Rexford S. Ahima · 2010 · Springer eBooks
  94. Pharmacological Management of the Obese Patient
    Donald Schumacher · 2013 · American Journal of Lifestyle Medicine
  95. Identification of Night Eating Behaviour and Investigation into Its Characteristics in an Obese Population
    Jacqueline Cleator · 2011 · CLOK (University of Central Lancashire)
  96. An Approach to Obesity as a Cardiometabolic Disease: Potential Implications for Clinical Practice
    2014 · BENTHAM SCIENCE PUBLISHERS eBooks
  97. Modulació farmacològica de l'oleoil-estrona sobre la ingesta i la composició corporal
    Raquel Ferrer Lorente · 2007 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  98. For information on reprint requests of more than 101 and commercial reprints contact
    Linda A. Barbour, Rhoda H. Cobin, Leslie J. DeGroot, Daniel Glinoer, Susan J. Mandel, Heather A. Edwards · 2008
  99. Pharmacotherapeutic Options for the Treatment of Patients with Obesity
    Lindsay R Debellis, Mark J. Wrobel · 2012 · Journal of Pharmacy Technology
  100. Treatment of Acute Manic and Mixed Episodes
    Paul E. Keck, Susan L. McElroy, Jeffrey Robert Strawn · 2008